7MYV
Plasmodium falciparum HAD5/PMM
Experimental procedure
Experimental method | SINGLE WAVELENGTH |
Source type | SYNCHROTRON |
Source details | APS BEAMLINE 19-ID |
Synchrotron site | APS |
Beamline | 19-ID |
Temperature [K] | 100 |
Detector technology | PIXEL |
Collection date | 2020-07-30 |
Detector | DECTRIS PILATUS3 X 6M |
Wavelength(s) | 0.98 |
Spacegroup name | P 65 2 2 |
Unit cell lengths | 161.255, 161.255, 109.738 |
Unit cell angles | 90.00, 90.00, 120.00 |
Refinement procedure
Resolution | 40.310 - 3.510 |
R-factor | 0.2593 |
Rwork | 0.254 |
R-free | 0.30710 |
Structure solution method | MOLECULAR REPLACEMENT |
Starting model (for MR) | 6cfr |
Data reduction software | HKL-3000 |
Data scaling software | SCALEPACK |
Phasing software | PHASER |
Refinement software | PHENIX (1.17.1_3660) |
Data quality characteristics
Overall | Outer shell | |
Low resolution limit [Å] | 40.316 | 3.560 |
High resolution limit [Å] | 3.500 | 3.500 |
Number of reflections | 11030 | 543 |
<I/σ(I)> | 18.5 | 2.7 |
Completeness [%] | 99.9 | 100 |
Redundancy | 32.1 | 30.1 |
Crystallization Conditions
crystal ID | method | pH | temperature | details |
1 | VAPOR DIFFUSION, HANGING DROP | 6.5 | 277 | 2ul drops containing 1:1 mixture of protein (6mg/mL) and crystallization buffer (0.1M bis -tris-propane pH 6.5, 0.1 M calcium acetate, 16% (w/v) PEG 8000, and 2% (v/v) benzamidine hydrochloride) |